Neonatal Kratom Withdrawal: What Parents Should Know
Neonatal kratom withdrawal, also known as Neonatal Abstinence Syndrome (NAS) due to kratom exposure, occurs when an infant experiences withdrawal symptoms after birth because the mother used kratom during pregnancy. This condition can present significant challenges for both the baby and the family, requiring careful medical attention and supportive care. Early recognition and appropriate intervention are key to managing these symptoms and promoting the infant's well-being.
Table of Contents
What is Neonatal Kratom Withdrawal?
Neonatal kratom withdrawal is a form of Neonatal Abstinence Syndrome (NAS) that can affect infants whose mothers used kratom during pregnancy. When a pregnant person uses kratom, the active compounds, including mitragynine and 7-hydroxymitragynine, can pass through the placenta to the developing fetus. After birth, when the infant is no longer exposed to these substances, they may experience withdrawal symptoms as their body adjusts.
The severity and duration of withdrawal symptoms can vary widely among infants, influenced by factors such as the amount and frequency of kratom use during pregnancy, the baby's gestational age, and individual metabolic differences. It is important to understand that kratom, despite being sometimes perceived as a 'natural' alternative, contains psychoactive compounds that can lead to physical dependence.
Recognizing Symptoms of Neonatal Kratom Withdrawal
Symptoms of neonatal kratom withdrawal can manifest shortly after birth or develop within the first few days of life. These symptoms often resemble those seen in other forms of NAS and can affect various bodily systems. Prompt recognition of these signs is crucial for initiating appropriate medical care.
Clinicians report that symptoms can range from mild to severe and may include a combination of issues. Parents and caregivers should be vigilant and communicate any concerns to their healthcare providers.
- Irritability and excessive crying
- Tremors or jitters
- Difficulty sleeping or restless sleep
- Poor feeding and weight gain
- Diarrhea and vomiting
- Sweating and fever
- Stuffy nose and sneezing
- Increased muscle tone
- Seizures (in severe cases, though less common)
Diagnosis and Treatment Approaches
Diagnosing neonatal kratom withdrawal typically involves a comprehensive assessment by healthcare professionals. This includes a review of the mother's prenatal history, a physical examination of the infant, and observation of withdrawal symptoms. Standardized scoring systems, such as the Finnegan Neonatal Abstinence Syndrome (NAS) score, are often used to quantify the severity of symptoms and guide treatment decisions.
Treatment for neonatal kratom withdrawal is primarily supportive and aims to alleviate the infant's symptoms and promote comfort. This may involve non-pharmacological interventions, such as swaddling, frequent small feedings, and a quiet environment. In some cases, medication may be necessary to manage severe withdrawal symptoms, carefully tapered to prevent further complications. The goal is to gradually wean the infant off the withdrawing substance and support their healthy development.
Supporting Your Baby Through Withdrawal
Supporting an infant experiencing neonatal kratom withdrawal can be challenging for parents, but there are many ways to help. Creating a calm and nurturing environment is paramount. Gentle handling, skin-to-skin contact, and consistent feeding schedules can provide comfort and stability. It's important for parents to work closely with their healthcare team to understand their baby's specific needs and follow medical advice.
Additionally, seeking support for yourself is vital. Resources such as support groups, counseling, and addiction recovery programs can provide invaluable assistance. Addressing any underlying substance use issues in the parent is also crucial for the long-term health and well-being of the entire family. Remember, you are not alone, and help is available.
Frequently Asked Questions
Nationally Certified Advanced Clinical Intervention Professional (NCACIP) · NAADAC Member · ISSUP Network Moderator
Benjamin Zohar is an addiction recovery professional, NAADAC member, and founder of Intervention New York (Intervention NY). A Nationally Certified Advanced Clinical Intervention Professional (NCACIP), he operates a statewide network of treatment navigation, placement, and crisis intervention services across New York, including the Hudson Valley Addiction Treatment Center, Long Island Addiction Treatment Resources, and Every1 Center. He specializes in clinical placement, structured family and executive interventions, and benefits navigation. As an ISSUP Network Moderator, he leads the Integrated Recovery & Intervention Education Network (IRIEN) and authors practical guides and peer-reviewed articles on emerging substance use threats. He also maintains active advocacy membership with the National Alliance on Mental Illness (NAMI).
Registered Nurse (RN) · Medical Reviewer
Registered nurse who reviews clinical content for medical accuracy, ensuring information on 7-OH and kratom dependence, withdrawal, and treatment reflects current evidence-based standards.
References
Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions about a medical condition or substance use. If you are experiencing a medical emergency, call 911.